Company intelligence / Profile preview
Polfa Tarchomin
Warsaw, Mazowieckie, Poland
- Ownership
- Private
- Employees
- ~9999
- Development stage
- Other
01
Overview
Polfa Tarchomin is a leading Polish and European generic drug producer with over 200 years of manufacturing history; is a major supplier in anti-infectives, insulin, and CNS/dermatology generics, and has recently launched a facility for oncological and immunosuppressive drug production
- Therapeutic areas
- EndocrinologyPsychiatryInfectious DiseasesDermatologyOncology
- Modalities
- Small moleculeBiologic (notably human insulin)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Polfa Tarchomin.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Polfa Tarchomin.